A galactosidase-responsive "trojan horse" for the selective targeting of folate receptor-positive tumor cells

ChemMedChem. 2011 Jun 6;6(6):1006-10. doi: 10.1002/cmdc.201100114. Epub 2011 Mar 25.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Doxorubicin / administration & dosage*
  • Doxorubicin / pharmacology*
  • Drug Delivery Systems*
  • Folate Receptors, GPI-Anchored / metabolism*
  • Humans
  • Ligands
  • Neoplasms / drug therapy
  • beta-Galactosidase / metabolism*

Substances

  • Antineoplastic Agents
  • Folate Receptors, GPI-Anchored
  • Ligands
  • Doxorubicin
  • beta-Galactosidase